Expression of MMP-2 and TIMP-1 in Renal Tissue of Patients with Chronic Active Antibody-mediated Renal Graft Rejection

Diagnostic Pathology

Volumn 7, Issue 1, 2012, Pages

  Yan, Qiang ^a   Sui, Weiguo ^a   Wang, Baoyao ^a   Zou, Hequn ^b   Zou, Guimian ^a   Luo, Hao ^c  

^a The 181th Hospital of PLA   (China)

^b THE THIRD AFFILIATED HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Chronic active antibody mediate rejection; Interstitial fibrosis and tubular atrophy; Matrix metalloproteinase 2; Tissue inhibitor of metalloproteinase 1

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENT C4D; COMPLEMENT COMPONENT C4B; CREATININE; GELATINASE A; MMP2 PROTEIN, HUMAN; PEPTIDE FRAGMENT; TIMP1 PROTEIN, HUMAN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTICLE; ATROPHY; BLOOD; CASE CONTROL STUDY; CHRONIC DISEASE; DISEASE COURSE; ENZYMOLOGY; FEMALE; FIBROSIS; GRAFT REJECTION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PATHOLOGY;

ADULT; ATROPHY; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHRONIC DISEASE; COMPLEMENT C4B; CREATININE; DISEASE PROGRESSION; FEMALE; FIBROSIS; GRAFT REJECTION; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; PEPTIDE FRAGMENTS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

MLCS; MLOWN;

EID: 84867291808     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-7-141     Document Type: Article

References (9)

1. Feucht HE, Schneeberger H, Hillebrand G, et al. Capillary deposition of C4d complements fragment and early renal graft loss. Kidney Int 1993, 43(6):1333-1338. 10.1038/ki.1993.187, 8315947.
2. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008, 8(4):753-760. 10.1111/j.1600-6143.2008.02159.x, 18294345.
3. Mackay AR, Gomez DE, Cottam DW, et al. Identification of the 72-kDa (MMP-2) and 92-kDa (MMP-9) gelatinase/type IV collagenase in preparations of laminin and Matrigel. Biotechniques 1993, 15(6):1048-1051.
4. Cheng S, Pollock AS, Mahimkar R, et al. Matrix metalloproteinase and basement membrane integrity: a unifying mechanism for progressive renal injury. FASEB J 2006, 20(11):1898-1900. 10.1096/fj.06-5898fje, 16891619.
5. Kitsiou PV, Tzinia AK, Stetler-Stevenson WG, et al. Glucoseinduced changes in integrins and matrix-related functions in cultured human glomerular epithelial cells. Am J Physiol Renal Physiol 2003, 284(4):671-679.
6. Berthier CC, Lods N, Joosten SA, et al. Differential regulation of metzincins in experimental chronic renal allograft rejection: potential markers and novel therapeutic targets. Kidney Int 2006, 69(2):358-368. 10.1038/sj.ki.5000049, 16408127.
7. Cai G, Zhang X, Hong Q, et al. Tissue inhibitor of metalloproteinase-1 exacerbated renal interstitial fibrosis through enhancing inflammation. Nephrol Dial Transplant 2008, 23(6):1861-1875. 10.1093/ndt/gfm666, 18326884.
8. Wagrowska-Danilewicz M, Danilewicz M. Dys- regulation of immunoexpression of matrix metalloproteinases in renal chronic allograft injury. Pol J Pathol 2009, 60(2):88-93.
9. Qin YH, Lei FY, Hu P, et al. Effect of all-trans retinoic acid on renal expressions of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rats with glomerulosclerosis. Pediatr Nephrol 2009, 24(8):1477-1486. 10.1007/s00467-009-1166-1, 19357873.